CFD-ji (pogodbe za razliko) so kompleksni instrumenti in so zaradi uporabe finančnega vzvoda povezani z visokim tveganjem za hitro izgubo denarja. 84% vlagateljev izgubi denar, ko trguje s CFD-ji pri tem ponudniku. Razmisliti morate, ali razumete, kako delujejo CFD-ji in ali si lahko privoščite tako visoko tveganje za izgubo svojega denarja.

Trgovina Pieris Pharmaceuticals, Inc. - PIRS CFD

0.81
10.96%
  • Povzetek
  • Zgodovinski podatki
  • Dogodki
  • Izkaz poslovnega izida
  • Bilanca stanja
  • Denarni tok
  • Lastništvo
Pogoji trgovanja
Razmik 0.05
Nočna pristojbina za nakup

Long position overnight fee


Margin. Your investment $1,000.00
Nočna pristojbina -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Pojdi na platformo
-0.025457%
Nočna pristojbina za prodajo

Short position overnight fee


Margin. Your investment $1,000.00
Nočna pristojbina 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Pojdi na platformo
0.003235%
Čas nočne pristojbine 21:00 (UTC)
Min. tržena količina 1
Valuta USD
Kritje 20%
Borza United States of America
Provizija na trgovanje 0%

*Information provided by Capital.com

Pieris Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Ključni statistični podatki
Predhodno. Zapri* 0.73
Odpri* 0.76
Enoletna sprememba* -55.56%
Dnevni razpon* 0.73 - 0.81
Razpon 52 wk 0.72-2.12
Povprečni obseg (10 dni) 743.53K
Povprečni obseg (3 meseci) 13.81M
Tržna kapitalizacija 61.51M
Razmerje P/E -100.00K
Število delnic v obtoku 82.02M
Prihodki 16.85M
EPS -0.56
Dividenda (donosnost v %) N/A
Beta 1.08
Datum naslednjega zaslužka Aug 2, 2023

Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Zapiranje Change Change (%) Odpiranje High Low
May 30, 2023 0.73 -0.05 -6.41% 0.78 0.78 0.72
May 26, 2023 0.72 -0.08 -10.00% 0.80 0.85 0.72
May 25, 2023 0.79 -0.04 -4.82% 0.83 0.84 0.79
May 24, 2023 0.85 -0.02 -2.30% 0.87 0.88 0.84
May 23, 2023 0.89 -0.03 -3.26% 0.92 0.92 0.86
May 22, 2023 0.84 0.02 2.44% 0.82 0.84 0.77
May 19, 2023 0.79 -0.07 -8.14% 0.86 0.87 0.78
May 18, 2023 0.83 0.02 2.47% 0.81 0.94 0.79
May 17, 2023 0.76 0.00 0.00% 0.76 0.79 0.74
May 16, 2023 0.77 -0.05 -6.10% 0.82 0.82 0.77
May 15, 2023 0.83 0.00 0.00% 0.83 0.85 0.78
May 12, 2023 0.84 -0.08 -8.70% 0.92 0.92 0.82
May 11, 2023 0.93 0.12 14.81% 0.81 0.96 0.76
May 10, 2023 0.84 0.06 7.69% 0.78 0.84 0.75
May 9, 2023 0.82 0.02 2.50% 0.80 0.82 0.73
May 8, 2023 0.80 -0.02 -2.44% 0.82 0.84 0.79
May 5, 2023 0.83 0.05 6.41% 0.78 0.85 0.78
May 4, 2023 0.77 -0.03 -3.75% 0.80 0.84 0.74
May 3, 2023 0.79 0.03 3.95% 0.76 0.80 0.72
May 2, 2023 0.74 0.03 4.23% 0.71 0.74 0.70

Pieris Pharmaceuticals, Inc. Events

Čas (UTC) (UTC) Država Dogodek
Wednesday, June 21, 2023

Čas (UTC) (UTC)

12:00

Država

US

Dogodek

Pieris Pharmaceuticals Inc Annual Shareholders Meeting
Pieris Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, June 22, 2023

Čas (UTC) (UTC)

12:00

Država

US

Dogodek

Pieris Pharmaceuticals Inc Annual Shareholders Meeting
Pieris Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, August 2, 2023

Čas (UTC) (UTC)

12:30

Država

US

Dogodek

Q2 2023 Pieris Pharmaceuticals Inc Earnings Release
Q2 2023 Pieris Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Tuesday, October 31, 2023

Čas (UTC) (UTC)

12:30

Država

US

Dogodek

Q3 2023 Pieris Pharmaceuticals Inc Earnings Release
Q3 2023 Pieris Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Oglejte si vse dogodke
  • Letni
  • Četrtletno
2022 2021 2020 2019 2018
Skupni prihodki 25.902 31.418 29.323 46.279 29.101
Prihodki 25.902 31.418 29.323 46.279 29.101
Celotni odhodki iz poslovanja 61.203 79.564 63.244 73.436 59.932
Celotna prodaja/splošni/upravni stroški Odhodki 16.394 16.593 16.713 18.44 18.442
Raziskave in razvoj 52.982 66.656 46.531 54.996 41.49
Prihodki iz poslovanja -35.301 -48.146 -33.921 -27.157 -30.831
Prihodki (odhodki) od obresti, neto Neoperativni 0.721 0.004 0.511 1.714 1.962
Drugo, neto 1.303 2.404 -3.656 -0.026 1.803
Čisti dobiček pred obdavčitvijo -33.277 -45.738 -37.066 -25.469 -27.066
Čisti dobiček po davkih -33.277 -45.738 -37.23 -25.469 -26.754
Čisti dobiček pred dodatnimi postavkami -33.277 -45.738 -37.23 -25.469 -26.754
Čisti dobiček -33.277 -45.738 -37.23 -25.469 -26.754
Total Adjustments to Net Income -2.83
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk -33.277 -45.738 -37.23 -28.299 -26.754
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami -33.277 -45.738 -37.23 -28.299 -26.754
Popravljen čisti dobiček -33.277 -45.738 -37.23 -28.299 -26.754
Popravljene ponderirane povprečne delnice 74.172 64.547 54.481 50.625 53.081
Popravljen dobiček na delnico brez upoštevanja izrednih postavk -0.44865 -0.7086 -0.68336 -0.55899 -0.50402
Popravljen normalizirani dobiček na enoto čistega dobička -0.55884 -0.76569 -0.68336 -0.55899 -0.50402
Skupaj izredne postavke
Nenavadni odhodki (prihodki) -8.173 -3.685
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Skupni prihodki 1.936 5.846 5.37 3.698 10.988
Prihodki 1.936 5.846 5.37 3.698 10.988
Celotni odhodki iz poslovanja 15.419 13.974 16.07 14.844 16.315
Celotna prodaja/splošni/upravni stroški Odhodki 4.023 3.985 3.949 4.081 4.379
Raziskave in razvoj 13.424 13.38 13.589 11.947 14.066
Prihodki iz poslovanja -13.483 -8.128 -10.7 -11.146 -5.327
Prihodki (odhodki) od obresti, neto Neoperativni 0.357 0.351 0.241 0.132 -0.003
Drugo, neto -0.057 -0.325 0.723 0.676 0.229
Čisti dobiček pred obdavčitvijo -13.183 -8.102 -9.736 -10.338 -5.101
Čisti dobiček po davkih -13.183 -8.102 -9.736 -10.338 -5.101
Čisti dobiček pred dodatnimi postavkami -13.183 -8.102 -9.736 -10.338 -5.101
Čisti dobiček -13.183 -8.102 -9.736 -10.338 -5.101
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk -13.183 -8.102 -9.736 -10.338 -5.101
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami -13.183 -8.102 -9.736 -10.338 -5.101
Popravljen čisti dobiček -13.183 -8.102 -9.736 -10.338 -5.101
Popravljene ponderirane povprečne delnice 74.519 74.448 74.397 74.125 73.711
Popravljen dobiček na delnico brez upoštevanja izrednih postavk -0.17691 -0.10883 -0.13087 -0.13947 -0.0692
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Popravljen normalizirani dobiček na enoto čistega dobička -0.20412 -0.15438 -0.1506 -0.15544 -0.0981
Nenavadni odhodki (prihodki) -2.028 -3.391 -1.468 -1.184 -2.13
  • Letni
  • Četrtletno
2022 2021 2020 2019 2018
Kratkoročna sredstva skupaj 73.424 127.625 75.721 115.013 135.382
Denarna sredstva in kratkoročne naložbe 59.169 117.764 70.436 104.154 128.107
Denarna sredstva in ustrezniki 38.635 117.764 70.436 62.26 74.867
Celotne terjatve, neto 5.81 3.313 1.706 6.787 2.701
Accounts Receivable - Trade, Net 5.81 3.313 1.706 6.787 2.701
Prepaid Expenses 8.445 6.548 3.579 4.072 4.574
Total Assets 95.49 153.56 105.01 141.097 141.341
Property/Plant/Equipment, Total - Net 20.697 23.031 25.98 22.938 5.049
Property/Plant/Equipment, Total - Gross 30.344 30.748 31.795 26.505 8.415
Accumulated Depreciation, Total -9.647 -7.717 -5.815 -3.567 -3.366
Other Long Term Assets, Total 1.369 2.904 3.309 3.146 0.91
Total Current Liabilities 36.583 50.561 22.145 27.003 48.076
Accounts Payable 4.154 8.609 1.787 5.803 3.35
Accrued Expenses 11.122 14.833 7.496 9.486 8.169
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 21.307 27.119 12.862 11.714 36.557
Total Liabilities 67.561 102.805 73.983 89.745 101.406
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 30.978 52.244 51.838 62.742 53.33
Total Equity 27.929 50.755 31.027 51.352 39.935
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.074 0.072 0.056 0.055 0.054
Additional Paid-In Capital 318.53 306.998 242.672 227.468 189.929
Retained Earnings (Accumulated Deficit) -290.421 -257.144 -211.406 -174.176 -147.066
Other Equity, Total -0.254 0.829 -0.295 -1.995 -2.982
Total Liabilities & Shareholders’ Equity 95.49 153.56 105.01 141.097 141.341
Total Common Shares Outstanding 74.5191 72.2227 56.0028 55.2124 54.1512
Kratkoročne naložbe 20.534 0 41.894 53.24
Long Term Investments 0
Total Preferred Shares Outstanding 0.00762 0.00762 0.01443 0.01143
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Kratkoročna sredstva skupaj 60.505 73.424 78.56 90.904 111.749
Denarna sredstva in kratkoročne naložbe 48.379 59.169 69.823 80.936 100.268
Denarna sredstva in ustrezniki 39.742 38.635 48.423 54.257 83.737
Celotne terjatve, neto 1.055 5.81 0.829 1.264 1.644
Accounts Receivable - Trade, Net 1.055 5.81 0.829 1.264 1.644
Prepaid Expenses 11.071 8.445 7.908 8.704 9.837
Total Assets 82.258 95.49 99.163 114.309 137.115
Property/Plant/Equipment, Total - Net 20.502 20.697 19.296 21.047 22.693
Property/Plant/Equipment, Total - Gross 30.476 30.344 27.615 29.292 30.87
Accumulated Depreciation, Total -9.974 -9.647 -8.319 -8.245 -8.177
Other Long Term Assets, Total 1.251 1.369 1.307 2.358 2.673
Total Current Liabilities 42.875 36.583 33.521 35.546 39.484
Accounts Payable 5.833 4.154 3.641 1.898 4.496
Accrued Expenses 9.764 11.122 10.801 10.175 11.858
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 27.278 21.307 19.079 23.473 23.13
Total Liabilities 66.8 67.561 63.396 69.944 83.665
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 23.925 30.978 29.875 34.398 44.181
Total Equity 15.458 27.929 35.767 44.365 53.45
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.074 0.074 0.074 0.074 0.074
Additional Paid-In Capital 319.414 318.53 317.488 316.249 314.668
Retained Earnings (Accumulated Deficit) -303.604 -290.421 -282.319 -272.583 -262.245
Other Equity, Total -0.426 -0.254 0.524 0.625 0.953
Total Liabilities & Shareholders’ Equity 82.258 95.49 99.163 114.309 137.115
Total Common Shares Outstanding 74.5191 74.5191 74.4062 74.2576 74.0979
Total Preferred Shares Outstanding 0.00762 0.00762 0.00762 0.00762 0.00762
Kratkoročne naložbe 8.637 20.534 21.4 26.679 16.531
  • Letni
  • Četrtletno
2022 2021 2020 2019 2018
Čisti prihodki/začetna postavka -33.277 -45.738 -37.23 -25.469 -26.754
Denarna sredstva iz poslovanja -59.932 -7.66 -45.896 -52.467 -1.066
Denarna sredstva iz poslovanja 2.77 2.459 2.311 0.632 0.57
Nedenarne postavke 3.945 5.094 5.236 4.491 3.389
Cash Taxes Paid 0 0.908
Denarna sredstva Plačane obresti
Spremembe v obratnem kapitalu -33.37 30.525 -16.377 -32.121 21.893
Denarna sredstva pri naložbenju -21.236 -0.949 39.212 9.838 -8.875
Kapitalski izdatki -1.041 -0.949 -2.726 -2.462 -1.698
Celotne druge postavke denarnih tokov pri naložbenju -20.195 0 41.938 12.3 -7.177
Denarna sredstva pri financiranju 7.214 59.127 10.115 32.166 48.511
Izdaja (odplačilo) delnic, neto 7.017 58.962 9.915 31.797 48.511
Učinki deviznih tečajev -5.175 -3.19 4.745 -2.144 -1.581
Neto sprememba denarnih sredstev -79.129 47.328 8.176 -12.607 36.989
Deferred Taxes 0 0.164 0 -0.164
Postavke denarnega toka pri financiranju 0.197 0.165 0.2 0.369
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -13.183 -33.277 -25.175 -15.439 -5.101
Cash From Operating Activities -10.996 -59.932 -46.999 -38.221 -22.643
Cash From Operating Activities 0.605 2.77 2.195 1.428 0.845
Non-Cash Items 0.975 3.945 3.37 2.728 1.264
Changes in Working Capital 0.607 -33.37 -27.389 -26.938 -19.651
Cash From Investing Activities 11.903 -21.236 -22.343 -27.813 -16.948
Capital Expenditures -0.048 -1.041 -1.052 -1.018 -0.389
Other Investing Cash Flow Items, Total 11.951 -20.195 -21.291 -26.795 -16.559
Cash From Financing Activities 0 7.214 7.121 6.839 6.558
Issuance (Retirement) of Stock, Net 0 7.017 7.017 6.735 6.558
Foreign Exchange Effects 0.2 -5.175 -7.12 -4.312 -0.994
Net Change in Cash 1.107 -79.129 -69.341 -63.507 -34.027
Financing Cash Flow Items 0.197 0.104 0.104
Deferred Taxes
Ime vlagatelja Vrsta vlagatelja Odstotek neporavnanih obveznosti Delnice v lasti Sprememba delnic Datum imetništva Ocena prometa
BVF Partners L.P. Hedge Fund 25.1281 20609863 15529543 2023-05-11 LOW
Lynx1 Capital Advisors LLC Investment Advisor 8.6172 7067718 1439133 2023-03-31
Aquilo Capital Management, LLC Investment Advisor/Hedge Fund 5.551 4552876 0 2023-03-31
Soleus Capital Management, L.P. Hedge Fund 5.0413 4134868 134868 2023-03-31 HIGH
Seagen Inc Corporation 4.5187 3706174 0 2022-12-31
AstraZeneca PLC Corporation 4.37 3584230 0 2022-12-31 LOW
Pontifax Ltd. Venture Capital 4.3544 3571428 0 2021-12-31 LOW
Marshall Wace LLP Investment Advisor/Hedge Fund 2.7632 2266350 -125686 2023-03-31 HIGH
Citadel Advisors LLC Hedge Fund 2.4383 1999907 -46254 2023-03-31 HIGH
Medical Strategy GmbH Investment Advisor 1.9744 1619387 52729 2023-01-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4366 1178283 -114163 2023-03-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.2626 1035540 -29441 2023-03-31 LOW
Platinum Asset Management Investment Advisor/Hedge Fund 1.1888 975012 -245786 2023-03-31 LOW
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.769 630690 -251144 2023-03-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7681 629965 0 2023-03-31 LOW
BMO Capital Markets (US) Research Firm 0.5873 481727 481727 2022-12-31 MED
Walleye Capital LLC Hedge Fund 0.5839 478935 478935 2023-03-31 LOW
Renaissance Technologies LLC Hedge Fund 0.4699 385391 -301600 2023-03-31 HIGH
Cutter & Company, Inc. Investment Advisor 0.4602 377479 -1000 2023-03-31 LOW
Candriam Belgium S.A. Investment Advisor/Hedge Fund 0.429 351834 -590000 2023-03-31 LOW

Zakaj izbrati Capital.com? Številke govorijo same zase.

Capital.com Group

530K+

Borzni posredniki

87K+

Aktivne stranke mesečno

$46M+

Mesečni obseg naložb

$31M+

Dvigi vsak mesec

Kalkulator trgovanja

Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).

Trgovalna provizija
0
  • 1:1
Vzvod
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje

Zapiranje

Kratka Dolga

Pieris Pharmaceuticals, Inc. Company profile

O družbi Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. je biotehnološko podjetje v klinični fazi, ki odkriva in razvija zdravila na osnovi antikalina za zdravljenje potrjenih bolezenskih poti. Vodilni kandidat za zdravilo za dihala, ki temelji na anticalinu, je PRS-060/AZD1402, ki antagonizira IL-4R alfa, s čimer zavira IL-4 in IL-13, dva citokina, majhne beljakovine, ki posredujejo signale med celicami v človeškem telesu in so znani kot posredniki v vnetni kaskadi, ki povzročajo patogenezo astme in drugih vnetnih bolezni. Vodilni kandidat za zdravilo na osnovi IO Anticalin, ki je v pripravi, je cinrebafusp alfa, ki je zasnovan tako, da cilja na imunski receptor 4-1BB in tumorsko tarčo HER2. Cinrebafusp alfa je genetska fuzija različice protitelesa, usmerjenega proti HER2, z beljakovino Anticalin, specifično za 4-1BB.

Industry: Bio Therapeutic Drugs

225 Franklin Street
26Th Floor
BOSTON
MASSACHUSETTS 02110
US

Izkaz poslovnega izida

  • Annual
  • Quarterly

Ljudje gledajo tudi

US100

14,290.70 Price
-0.560% 1D Chg, %
Nočna pristojbina za nakup -0.0255%
Nočna pristojbina za prodajo 0.0032%
Čas nočne pristojbine 21:00 (UTC)
Razmik 1.8

Gold

1,964.76 Price
+0.260% 1D Chg, %
Nočna pristojbina za nakup -0.0089%
Nočna pristojbina za prodajo 0.0006%
Čas nočne pristojbine 21:00 (UTC)
Razmik 0.30

Oil - Crude

68.22 Price
-2.010% 1D Chg, %
Nočna pristojbina za nakup -0.0208%
Nočna pristojbina za prodajo -0.0011%
Čas nočne pristojbine 21:00 (UTC)
Razmik 0.03

BTC/USD

27,072.85 Price
-2.640% 1D Chg, %
Nočna pristojbina za nakup -0.0616%
Nočna pristojbina za prodajo 0.0137%
Čas nočne pristojbine 21:00 (UTC)
Razmik 60.00

Še vedno iščete posrednika, ki mu lahko zaupate?

Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com

1. Ustvarite in preverite svoj račun 2. Naredite polog 3. Poiščite svoje trgovanje